USPTO serial 88232942
INHERIS
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- ANDERSON, CASSONDRA CR
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INHERIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA
San Francisco, CA
CHICAGO, IL
CHICAGO, IL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer D. Arkowitz
Jennifer D. Arkowitz KILPATRICK TOWNSEND & STOCKTON LLP1100 PEACHTREE STREET, SUITE 2800Mailstop: IP Docketing - 22ATLANTA, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, namely, pharmaceutical preparations having enhanced drug performance and/or drug delivery performance for the treatment and/or prophylaxis of diseases or medical conditions such as pain, diabetes, infections, cancers, and inflammations, or of diseases or medical conditions that affect the peripheral nerves, the adrenergic and/or cholinergic receptors, the histamine receptors, the expression and/or regulation of growth factors, the skeletal and/or smooth muscle systems, the cardiovascular system, the endocrine and/or hormone systems, the blood circulatory system, the immunological system, the synoptic and neuroeffector junctional sites, the reproductive system, the skeletal system, the autocoid system, the alimentary and/or excretory systems, and/or the central nervous system | ABANDONED | — |
| 042 | Research services, namely, providing research and development services for others in the biotechnical, biomedical and pharmaceutical fields | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nektar Therapeutics
- Other trademarks owned by Nektar Therapeutics
- Other trademarks owned by Inheris Biopharma, Inc.
- Other trademarks owned by INHERIS PHARMACEUTICALS, INC.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named INHERIS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2020 | MAB5 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION | — |
| May 13, 2020 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| May 12, 2020 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| May 11, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 11, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 11, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 8, 2020 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jan 7, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 6, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 6, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 20, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 20, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 27, 2019 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 25, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 9, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 21, 2018 | NWAP | NEW APPLICATION ENTERED | — |